Market Overview:
The global central nervous system (CNS) therapeutics market size reached US$ 121.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 185.62 Billion by 2027, exhibiting a growth rate (CAGR) of 7.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The central nervous system (CNS) represents a vital part of the nervous system that comprises of the brain and the spinal cord. It integrates the received information, thereafter coordinating and controlling the activities of all parts of the body. CNS therapeutics primarily include anesthetics, anticonvulsants, CNS stimulants, muscle relaxants, narcotic analgesics, sedatives, etc. They are widely adopted in the treatment procedures of Parkinson’s disease, depression, Alzheimer’s disease, epilepsy, traumatic brain, spinal cord injury, CNS cancer, etc.
Central Nervous System (CNS) Therapeutics Market Trends:
The elevating prevalence of mental illness and lifestyle-associated CNS disorders, including anxiety, depression, hypertension, etc., is primarily driving the global CNS therapeutics market. In line with this, the growing geriatric population, who are more prone to chronic neurological ailments such as Alzheimer’s disease and Parkinson’s disease, is also propelling the global market. Additionally, the emerging popularity of generic neurologic drugs across developing countries on account of their affordability is further augmenting the market for CNS therapeutics. Apart from this, continuous innovations in CNS treatment procedures, such as the development of gene therapy, neurostimulation tools, and neural transplantation techniques, are also stimulating the market growth. These approaches prolong the action of unremitting dopaminergic stimulation medicines and control disease progression. Moreover, the introduction of novel drug-delivery systems that provide ease of administration and availability of different dosage forms is further creating a positive outlook for the global CNS market. For instance, transdermal patches are gaining traction in the field of neurology to treat CNS disorders as they offer a precise amount of medicine and relief for around 24 hours. Besides this, the increasing focus of the government and non-government organizations on creating awareness regarding numerous CNS disorders and the accessibility to multiple treatment options is also catalyzing the market growth. Moreover, the launch of favorable guidelines to support faster approvals of pipeline drugs for neurodegenerative diseases and clinical trials that encourage the entry of new products is expected to drive the global central nervous system therapeutics market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global central nervous system (CNS) therapeutics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease and application.
Breakup by Disease:
- Neurodegenerative Diseases
- Alzheimer's Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Huntington's Disease
- Amyotrophic Lateral Sclerosis
- Others
- Neurovascular Diseases
- CNS Trauma
- Mental Health
- Anxiety Disorders
- Epilepsy
- Mood Disorders
- Psychotic Disorders
- Others
- Infectious Diseases
- CNS Cancer
- Others
Breakup by Application:
- Hospital
- Clinic
- Homecare
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Disease, Application, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
AstraZeneca plc, Biogen Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG (Roche Holding), H. Lundbeck A/S, Merck & Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global central nervous system (CNS) therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global central nervous system (CNS) therapeutics market?
- What are the key regional markets?
- What is the breakup of the market based on the disease?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global central nervous system (CNS) therapeutics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Central Nervous System (CNS) Therapeutics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease
6.1 Neurodegenerative Diseases
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Alzheimer's Disease
6.1.2.2 Parkinson’s Disease
6.1.2.3 Multiple Sclerosis
6.1.2.4 Huntington's Disease
6.1.2.5 Amyotrophic Lateral Sclerosis
6.1.2.6 Others
6.1.3 Market Forecast
6.2 Neurovascular Diseases
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 CNS Trauma
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mental Health
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Anxiety Disorders
6.4.2.2 Epilepsy
6.4.2.3 Mood Disorders
6.4.2.4 Psychotic Disorders
6.4.2.5 Others
6.4.3 Market Forecast
6.5 Infectious Diseases
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 CNS Cancer
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Application
7.1 Hospital
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Clinic
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Homecare
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AstraZeneca plc
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biogen Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eli Lilly and Company
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 F. Hoffmann-La Roche AG (Roche Holding)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 H. Lundbeck A/S
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Merck & Co. Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Neurocrine Biosciences Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Novartis AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Pfizer Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Sanofi S.A.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Takeda Pharmaceutical Company Limited
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Teva Pharmaceutical Industries Ltd.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Central Nervous System Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Central Nervous System Therapeutics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Central Nervous System Therapeutics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Central Nervous System Therapeutics Market: Breakup by Disease (in %), 2021
Figure 5: Global: Central Nervous System Therapeutics Market: Breakup by Application (in %), 2021
Figure 6: Global: Central Nervous System Therapeutics Market: Breakup by Region (in %), 2021
Figure 7: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Central Nervous System Therapeutics (Neurodegenerative Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Central Nervous System Therapeutics (Neurovascular Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Central Nervous System Therapeutics (CNS Trauma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Central Nervous System Therapeutics (CNS Trauma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Central Nervous System Therapeutics (Mental Health) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Central Nervous System Therapeutics (Mental Health) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Central Nervous System Therapeutics (Infectious Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Central Nervous System Therapeutics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Central Nervous System Therapeutics (CNS Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Central Nervous System Therapeutics (CNS Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Central Nervous System Therapeutics (Other Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Central Nervous System Therapeutics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Central Nervous System Therapeutics (Hospital) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Central Nervous System Therapeutics (Hospital) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Central Nervous System Therapeutics (Clinic) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Central Nervous System Therapeutics (Clinic) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Central Nervous System Therapeutics (Homecare) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Central Nervous System Therapeutics (Homecare) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Central Nervous System Therapeutics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Central Nervous System Therapeutics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: North America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: North America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: United States: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia-Pacific: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia-Pacific: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: China: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: China: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Japan: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Japan: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: India: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: India: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: South Korea: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: South Korea: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Australia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Australia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Indonesia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Indonesia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Europe: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Europe: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Germany: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Germany: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: France: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: France: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United Kingdom: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United Kingdom: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Italy: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Italy: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Spain: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Spain: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Russia: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Russia: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Latin America: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Latin America: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Brazil: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Brazil: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Mexico: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Mexico: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Middle East and Africa: Central Nervous System Therapeutics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Middle East and Africa: Central Nervous System Therapeutics Market: Breakup by Country (in %), 2021
Figure 77: Middle East and Africa: Central Nervous System Therapeutics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Global: Central Nervous System Therapeutics Industry: SWOT Analysis
Figure 79: Global: Central Nervous System Therapeutics Industry: Value Chain Analysis
Figure 80: Global: Central Nervous System Therapeutics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Central Nervous System Therapeutics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 3: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Central Nervous System Therapeutics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Central Nervous System Therapeutics Market: Competitive Structure
Table 6: Global: Central Nervous System Therapeutics Market: Key Players